Last updated on February 2019

Phase II Study Evaluating the Efficacy and the Safety of Regorafenib in Patients Aged More Than 70 Years With a Metastatic Colorectal Adenocarcinoma .

Brief description of study

Multicenter prospective phase II study evaluating regorafenib in older patients with metastatic colorectal cancer

Clinical Study Identifier: NCT02788006

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.